These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 30720174)
1. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells. Yang J; Du YM; Li B Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174 [TBL] [Abstract][Full Text] [Related]
2. CD151 promotes breast cancer metastasis by activating TGF-β1/Smad signaling pathway. Zhao SJ; Zhao HD; Li J; Zhang H; Gao DT; Wang Q Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7314-7322. PubMed ID: 30468476 [TBL] [Abstract][Full Text] [Related]
3. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway. Gao BB; Wang SX Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107. Wu XF; Lu JT; Chen W; Wang N; Meng JC; Zhou YH Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA BX357664 regulates cell proliferation and epithelial-to-mesenchymal transition via inhibition of TGF-β1/p38/HSP27 signaling in renal cell carcinoma. Liu Y; Qian J; Li X; Chen W; Xu A; Zhao K; Hua Y; Huang Z; Zhang J; Liang C; Su S; Li P; Shao P; Li J; Qin C; Wang Z Oncotarget; 2016 Dec; 7(49):81410-81422. PubMed ID: 27806310 [TBL] [Abstract][Full Text] [Related]
6. MiRNA-199 inhibits malignant progression of lung cancer through mediating RGS17. Su WZ; Ren LF Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3390-3400. PubMed ID: 31081094 [TBL] [Abstract][Full Text] [Related]
7. lncRA ANCR Inhibits Non-Small Cell Lung Cancer Cell Migration and Invasion by Inactivating TGF-β Pathway. Wang S; Lan F; Xia Y Med Sci Monit; 2018 Aug; 24():6002-6009. PubMed ID: 30154397 [TBL] [Abstract][Full Text] [Related]
8. LncRNA HAND2-AS1 inhibits non-small cell lung cancer migration, invasion and maintains cell stemness through the interactions with TGF-β1. Miao F; Chen J; Shi M; Song Y; Chen Z; Pang L Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509963 [TBL] [Abstract][Full Text] [Related]
9. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer. Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597 [TBL] [Abstract][Full Text] [Related]
10. Linc8087 predicts favorable prognosis and inhibits cell migration and invasion in NSCLC. Qi Q; Chen C; Liu C; Zhang B; Ma Y; Zhang H; Huang W; Wang C Pathol Res Pract; 2021 Sep; 225():153569. PubMed ID: 34391179 [TBL] [Abstract][Full Text] [Related]
11. LncRNA WT1-AS over-expression inhibits non-small cell lung cancer cell stemness by down-regulating TGF-β1. Jiang X; Wang J; Fang L BMC Pulm Med; 2020 Apr; 20(1):113. PubMed ID: 32349718 [TBL] [Abstract][Full Text] [Related]
12. Effects of long non-coding RNA (lncRNA) cancer susceptibility candidate 2c (CASC2c) on proliferation, metastasis and drug resistance of non-small cell lung cancer (NSCLC) cells through ERK1/2 and β-catenin signaling pathways. Tong L; Wu W Pathol Res Pract; 2019 Sep; 215(9):152522. PubMed ID: 31300295 [TBL] [Abstract][Full Text] [Related]
13. LncRNA GASL1 inhibits tumor growth of non-small cell lung cancer by inactivating TGF-β pathway. Su WZ; Yuan X Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7282-7288. PubMed ID: 30468472 [TBL] [Abstract][Full Text] [Related]
14. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway. Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA ASAP1-IT1 promotes cell proliferation, invasion and metastasis through the PTEN/AKT signaling axis in non-small cell lung cancer. Zhang L; Shi SB; Zhu Y; Qian TT; Wang HL Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):142-149. PubMed ID: 29364481 [TBL] [Abstract][Full Text] [Related]
16. FOXD3-AS1 suppresses the progression of non-small cell lung cancer by regulating miR-150/SRCIN1axis. Ji T; Zhang Y; Wang Z; Hou Z; Gao X; Zhang X Cancer Biomark; 2020; 29(3):417-427. PubMed ID: 32924985 [TBL] [Abstract][Full Text] [Related]
17. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1. Zeng TD; Zheng B; Zheng W; Chen C Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-16 inhibits the proliferation, migration and invasion of non-small cell lung carcinoma cells by down-regulating matrix metalloproteinase-19 expression. Tian G; Wang SW; Song M; Hu YF; Cao XN; Ge JW Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5260-5269. PubMed ID: 31298377 [TBL] [Abstract][Full Text] [Related]
19. LncRNA NBR2 Regulates Cancer Cell Stemness and Predicts Survival in Non-small Cell Cancer Patients by Downregulating TGF-β1. Huang J; Yu Q; Zhang J; Lu W; Liu Q; Chu Y; Zhou Y; Tu R; Zhou H; Wang Q Curr Pharm Biotechnol; 2023; 24(8):1059-1069. PubMed ID: 35909269 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA HOTAIR regulates the development of non-small cell lung cancer through miR-217/DACH1 signaling pathway. Chen SS; Peng M; Zhou GZ; Pu YC; Yi MC; Zhu Y; Jiang B Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):670-678. PubMed ID: 30720199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]